Literature DB >> 18524768

Synaptic vesicle protein 2 binds adenine nucleotides.

Jia Yao1, Sandra M Bajjalieh.   

Abstract

Synaptic vesicle protein 2 (SV2) is required for normal calcium-regulated secretion of hormones and neurotransmitters. Neurons lacking the two most widely expressed isoforms, SV2A and SV2B, have a reduced readily releasable pool of synaptic vesicles, indicating that SV2 contributes to vesicle priming. The presence of putative ATP-binding sites in SV2 suggested that SV2 might be an ATP-binding protein. To explore this, we examined the binding of the photoaffinity reagent 8-azido-ATP[gamma] biotin to purified, recombinant SV2 in the presence and absence of other nucleotides. Our results indicate that SV2A and SV2B bind nucleotides, with the highest affinity for adenine-containing nucleotides. SV2A contains two binding sites located in the cytoplasmic domains preceding the first and seventh transmembrane domains. These results suggest that SV2-mediated vesicle priming could be regulated by adenine nucleotides, which might provide a link between cellular energy levels and regulated secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524768      PMCID: PMC2475693          DOI: 10.1074/jbc.M800738200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Structural model for 12-helix transporters belonging to the major facilitator superfamily.

Authors:  Teruhisa Hirai; Jürgen A W Heymann; Peter C Maloney; Sriram Subramaniam
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

2.  Structural conservation in the major facilitator superfamily as revealed by comparative modeling.

Authors:  Eyal Vardy; Isaiah T Arkin; Kay E Gottschalk; H Ronald Kaback; Shimon Schuldiner
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

3.  Identification of a vesicular nucleotide transporter.

Authors:  Keisuke Sawada; Noriko Echigo; Narinobu Juge; Takaaki Miyaji; Masato Otsuka; Hiroshi Omote; Akitsugu Yamamoto; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

4.  SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.

Authors:  R Janz; Y Goda; M Geppert; M Missler; T C Südhof
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

5.  SV2 modulates the size of the readily releasable pool of secretory vesicles.

Authors:  T Xu; S M Bajjalieh
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

6.  Molecular determinants of sugar transport regulation by ATP.

Authors:  Kara B Levine; Erin K Cloherty; Stephanie Hamill; Anthony Carruthers
Journal:  Biochemistry       Date:  2002-10-22       Impact factor: 3.162

7.  Mutational analysis of basic residues in the rat vesicular acetylcholine transporter. Identification of a transmembrane ion pair and evidence that histidine is not involved in proton translocation.

Authors:  M H Kim; M Lu; M Kelly; L B Hersh
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

8.  The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

Authors:  Berkley A Lynch; Nathalie Lambeng; Karl Nocka; Patricia Kensel-Hammes; Sandra M Bajjalieh; Alain Matagne; Bruno Fuks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

9.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells.

Authors:  K Buckley; R B Kelly
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

View more
  17 in total

1.  An Epilepsy-Associated SV2A Mutation Disrupts Synaptotagmin-1 Expression and Activity-Dependent Trafficking.

Authors:  Callista B Harper; Christopher Small; Elizabeth C Davenport; Darryl W Low; Karen J Smillie; Ramón Martínez-Mármol; Frédéric A Meunier; Michael A Cousin
Journal:  J Neurosci       Date:  2020-04-27       Impact factor: 6.167

Review 2.  Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

Authors:  Kristine Ciruelas; Daniele Marcotulli; Sandra M Bajjalieh
Journal:  Semin Cell Dev Biol       Date:  2019-03-21       Impact factor: 7.727

3.  Cotrafficking of SV2 and synaptotagmin at the synapse.

Authors:  Jia Yao; Amy Nowack; Patricia Kensel-Hammes; Richard G Gardner; Sandra M Bajjalieh
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

4.  Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.

Authors:  V Daniels; M Wood; K Leclercq; R M Kaminski; M Gillard
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

5.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 6.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

7.  Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures.

Authors:  Hang Xing; Xiong Han; Sihan Xu; Zhongyu Sun; Shijun Yang
Journal:  J Mol Neurosci       Date:  2022-03-12       Impact factor: 3.444

8.  All-optical monitoring of excitation-secretion coupling demonstrates that SV2A functions downstream of evoked Ca2+ entry.

Authors:  Mazdak M Bradberry; Edwin R Chapman
Journal:  J Physiol       Date:  2022-01-13       Impact factor: 5.182

9.  Central presynaptic terminals are enriched in ATP but the majority lack mitochondria.

Authors:  Vrushali Chavan; Jeffery Willis; Sidney K Walker; Helen R Clark; Xinran Liu; Michael A Fox; Sarika Srivastava; Konark Mukherjee
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

10.  SVOP is a nucleotide binding protein.

Authors:  Jia Yao; Sandra M Bajjalieh
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.